These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31100216)
1. Downregulation of aspartoacylase during the progression of myelin breakdown in the dmy mutant rat with mitochondrial magnesium channel MRS2 defect. Kuwamura M; Tanimura S; Hasegawa Y; Hoshiai R; Moriyama Y; Tanaka M; Takenaka S; Nagayoshi H; Izawa T; Yamate J; Kuramoto T; Serikawa T Brain Res; 2019 Sep; 1718():169-175. PubMed ID: 31100216 [TBL] [Abstract][Full Text] [Related]
2. Oligodendroglial pathology in the development of myelin breakdown in the dmy mutant rat. Kuwamura M; Inumaki K; Tanaka M; Shirai M; Izawa T; Yamate J; Franklin RJ; Kuramoto T; Serikawa T Brain Res; 2011 May; 1389():161-8. PubMed ID: 21396920 [TBL] [Abstract][Full Text] [Related]
3. A mutation in the gene encoding mitochondrial Mg²+ channel MRS2 results in demyelination in the rat. Kuramoto T; Kuwamura M; Tokuda S; Izawa T; Nakane Y; Kitada K; Akao M; Guénet JL; Serikawa T PLoS Genet; 2011 Jan; 7(1):e1001262. PubMed ID: 21253565 [TBL] [Abstract][Full Text] [Related]
4. Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. Traka M; Wollmann RL; Cerda SR; Dugas J; Barres BA; Popko B J Neurosci; 2008 Nov; 28(45):11537-49. PubMed ID: 18987190 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of aspartoacylase in the rat central nervous system. Madhavarao CN; Moffett JR; Moore RA; Viola RE; Namboodiri MA; Jacobowitz DM J Comp Neurol; 2004 May; 472(3):318-29. PubMed ID: 15065127 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats. Shimotsuma Y; Tanaka M; Izawa T; Yamate J; Kuwamura M PLoS One; 2016; 11(12):e0168250. PubMed ID: 27977799 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and morphometrical studies on myelin breakdown in the demyelination (dmy) mutant rat. Kuwamura M; Kanehara T; Tokuda S; Kumagai D; Yamate J; Kotani T; Nakane Y; Kuramoto T; Serikawa T Brain Res; 2004 Oct; 1022(1-2):110-6. PubMed ID: 15353220 [TBL] [Abstract][Full Text] [Related]
8. Myelin lesion in the aspartoacylase (Aspa) knockout rat, an animal model for Canavan disease. Takeda S; Hoshiai R; Tanaka M; Izawa T; Yamate J; Kuramoto T; Kuwamura M Exp Anim; 2024 Jul; 73(3):347-356. PubMed ID: 38538326 [TBL] [Abstract][Full Text] [Related]
9. Extensive aspartoacylase expression in the rat central nervous system. Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311 [TBL] [Abstract][Full Text] [Related]
10. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013 [TBL] [Abstract][Full Text] [Related]
11. Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism. Lotun A; Li D; Xu H; Su Q; Tuncer S; Sanmiguel J; Mooney M; Baer CE; Ulbrich R; Eyles SJ; Strittmatter L; Hayward LJ; Gessler DJ; Gao G Prog Neurobiol; 2023 Jul; 226():102460. PubMed ID: 37149081 [TBL] [Abstract][Full Text] [Related]
13. Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat. Izawa T; Yamate J; Franklin RJ; Kuwamura M Brain Res; 2010 Aug; 1349():105-14. PubMed ID: 20599839 [TBL] [Abstract][Full Text] [Related]
14. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time. Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242 [TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase. Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881 [TBL] [Abstract][Full Text] [Related]
16. Canavan disease: a white matter disorder. Kumar S; Mattan NS; de Vellis J Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907 [TBL] [Abstract][Full Text] [Related]
17. Abnormal myelinogenesis both in the white and gray matter of the attractin-deficient mv rat. Izawa T; Yamate J; Franklin RJ; Kuwamura M Brain Res; 2010 Feb; 1312():145-55. PubMed ID: 19931230 [TBL] [Abstract][Full Text] [Related]
18. Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination. Kirmani BF; Jacobowitz DM; Namboodiri MA Brain Res Dev Brain Res; 2003 Jan; 140(1):105-15. PubMed ID: 12524181 [TBL] [Abstract][Full Text] [Related]
19. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Wang J; Leone P; Wu G; Francis JS; Li H; Jain MR; Serikawa T; Ledeen RW Neurochem Res; 2009 Jan; 34(1):138-48. PubMed ID: 18478328 [TBL] [Abstract][Full Text] [Related]